ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

NIH Dedicates Louis Stokes Laboratories; Royston Retires As Kimmel Center President.

June 22, 2001

Gori to Hopkins Part Time, Keeps DCCP Deputy Job

September 1, 1978

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005